HUTCHMED (H7T1) Financial Statements
HUTCHMED Financial Overview
HUTCHMED's market cap is currently $2.06B. The company's EPS TTM is $0.10; its P/E ratio is 143.19; HUTCHMED is estimated to report earnings on March 4, 2027, and the estimated EPS forecast is $0.18. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 549.96M | $ 630.20M | $ 838.00M | $ 426.41M | $ 356.13M |
| Gross Profit | $ 212.72M | $ 282.57M | $ 453.55M | $ 115.31M | $ 327.34M |
| Operating Income | $ -54.73M | $ -43.70M | $ 18.38M | $ -718.80M | $ -357.10M |
| EBITDA | $ -41.42M | $ -31.36M | $ 26.58M | $ -351.35M | $ -147.34M |
| Net Income | $ 458.12M | $ 37.73M | $ 100.78M | $ -360.83M | $ -194.65M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.37B | $ 836.11M | $ 886.34M | $ 631.00M | $ 1.01B |
| Total Assets | $ 1.75B | $ 1.27B | $ 1.28B | $ 1.03B | $ 1.37B |
| Total Debt | $ 97.89M | $ 89.82M | $ 86.13M | $ 27.01M | $ 38.98M |
| Net Debt | $ 26.56M | $ -64.14M | $ -197.46M | $ -286.27M | $ -338.56M |
| Total Liabilities | $ 501.84M | $ 502.34M | $ 536.39M | $ 392.57M | $ 333.15M |
| Stockholders' Equity | $ 1.24B | $ 759.93M | $ 730.54M | $ 610.37M | $ 986.89M |
| Cash Flow | |||||
| Free Cash Flow | $ -88.81M | $ -17.44M | $ 186.65M | $ -305.26M | $ -220.98M |
| Operating Cash Flow | $ -64.66M | $ 497.00K | $ 219.26M | $ -268.60M | $ -204.22M |
| Investing Cash Flow | $ -29.41M | $ -96.06M | $ -291.14M | $ 296.59M | $ -306.32M |
| Financing Cash Flow | $ 7.84M | $ -30.67M | $ 48.66M | $ -82.76M | $ 650.03M |
Currency in USD